CVS · CVS Health Corp
United States · RS rating 72 · As of 2026-11-03
| Price | 91.41 USD |
|---|---|
| 1-day change | +3.3% |
| RS rating (overall / 1M / 3M / 12M) | 72 / 73 / 51 / 68 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 46 / 36 / 64 |
| Industry group (rank) | Medical-Managed Care (13) |
| EPS growth Q/Q | +173.5% |
| Sales growth Q/Q | +2.7% |
| Distance from 52-week high | +17.4% |
| Market cap (USD) | $101.1B |